Breaking News

Fujifilm Completes Acquisition of Biogen’s Manufacturing Site in Denmark

Invests roughly $890 million in project

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Fujifilm Corporation has completed the acquisition of Biogen (Denmark) Manufacturing ApS, a large-scale biologics manufacturing site located in Hillerød near Copenhagen, Denmark from Biogen. Fujifilm invested approximately $890 million for the transaction.   With the closing of this transaction, the Hillerød Manufacturing site is now the fourth biopharmaceutical manufacturing site of Fujifilm Diosynth Biotechnologies, a subsidiary of Fujifilm and a leading contract development and manufacturing ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters